Using biomarkers has helped to improve response rates in adult cancers from 4-50%. We urgently need to get new treatments to children with neuroblastoma, but can’t test their effectiveness using adult methods. This project is looking how we can adapt MRI techniques to speed up testing and monitoring new treatments.
Neuroblastoma is the second most common solid tumour in children, and several promising new therapies are being tested in research laboratories. But we need to find a way to test these drugs more quickly so that we can get them to the children who need them.
Accelerating Personalised Treatment for Children with Neuroblastoma with MRI Biomarkers
Dr Yann Jamin
Institute of Cancer Research
Sutton, SM2 5NG
1 October 2014